Mackenzie Financial’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19M Buy
37,374
+19,679
+111% +$825K ﹤0.01% 1030
2026
Q1
$570K Sell
17,695
-5,442
-24% -$201K ﹤0.01% 1196
2025
Q4
$976K Sell
23,137
-17,209
-43% -$694K ﹤0.01% 1063
2025
Q3
$1.39M Buy
40,346
+32,705
+428% +$938K ﹤0.01% 967
2025
Q2
$207K Buy
+7,641
New +$221K ﹤0.01% 1547
2025
Q1
Sell
-5,880
Closed -$233K 1806
2024
Q4
$233K Hold
5,880
﹤0.01% 1495
2024
Q3
$200K Buy
+5,880
New +$165K ﹤0.01% 1393
2021
Q4
Sell
-6,728
Closed -$313K 1509
2021
Q3
$313K Buy
6,728
+1,238
+23% +$54K ﹤0.01% 1122
2021
Q2
$219K Buy
+5,490
New +$235K ﹤0.01% 1147
2019
Q4
Sell
-15,400
Closed -$370K 1164
2019
Q3
$370K Buy
15,400
+1,550
+11% +$41.2K ﹤0.01% 865
2019
Q2
$395K Buy
+13,850
New +$346K ﹤0.01% 893

Other funds holding VCYT

Mackenzie Financial's VCYT Position: Q2 2026 in Review

Mackenzie Financial increased its Veracyte (VCYT) stake by 111% in Q2 2026, buying an estimated $825K and bringing the position to 37,374 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

Mackenzie Financial first reported a position in VCYT in Q2 2019 and has held it in 11 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Mackenzie Financial held 37,374 shares of Veracyte worth $2.19M as of Q2 2026.
  • Mackenzie Financial bought 19,679 Veracyte shares in Q2 2026, an estimated $825K.
  • Veracyte made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1030 holding.
  • Mackenzie Financial first reported a position in Veracyte in Q2 2019 and has held it in 11 quarters since.
  • 371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.